Serum Endocan Levels and Gestational Diabetes

In diabetic patients, serum endocan level has been significantly increased in patients and the levels on the long-term complications are correlated. Based on the Iinformation obtained from these studies, it can be said that there is a strong association between diabetes and serum endocan levels.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gestational Diabetes Diabetes Mellitus Diabetes, Gestational Endocan Endocrine System Diseases Female Urogenital Diseases and Pregnancy Complications Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases Pregnancy Complications Urogenital Diseases

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Gaziosmanpaşa Treh

Istanbul, Gaziosmanpaşa, 34000, Turkey (Türkiye)

About this study

It has been shown that endocan level of plasental tissue in gestational diabtes patients is significantly increased when looking at the same week compared with plasenta tissue samples of helathy pregnancy. From the information obtained from these studies, it can be said that there is a strong association between diabetes mellitus and serum endocan levels. investigators aimed to determine the relationship between serum endocan levels and gestational diabetes in the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

being pregnant at 24-26 weeks of gestation
having oral glucose toleranse screening test
age between 18-45 years

Exclusion criteria

having in utero mort fetus
having a previous diagnosis of diabetes
having a multiple pregnancy
having a coronary artery disease
having preeclampcia
having a pregnancy obtained by assisted reproductive technology
using cigarette
using alcohol

Treatment and study plan

Serum Endocan Levels

Diagnostic Test

Detection of Serum Endocan Levels and detection of possible diagnostic association with gestational diabetes

Primary outcomes

Detection of diagnostic value of serum endocan levels in patient with gestational diabetes

Time frame: 3 months

Identifying diagnostic value of serum endocan by comparing serum levels of endocan in groups.

Sponsors and collaborators

Lead sponsor

Gaziosmanpasa Research and Education Hospital

Other Gov

Registry information

Official study title

Evaluation of Serum Endocan Levels in Patients With Gestational Diabetes

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Feb 14, 2022
Registry last updated: Aug 5, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed